Become a member
Quick Registration
Full Registration Benefits -
Free Homepages for Doctors
Free Homepages for Hospitals
Free Homepages for Medical Conference
Free Homepages for NGO's
Personal Health Record Creation
Access to all Medical Slides
Access to all Jobs & Products Sale
Asparaginase
Latest prescription information about Asparaginase. Learn how to pronounce the drug’s name, its indications, dosage, how to take, when to take, when not to take, side effects, special precautions, its storage instructions and warnings if any when taken during pregnancy. Also listed are the International and Indian trade name(s) of the drug and its price list.
|
Generic Name : Asparaginase
Pronunciation : a spare' a gi nase
Therapeutic Classification : Chemotherapy Trade Name(s): India- Asginase Vial, Celginase Inj, L-Aspase Vial, Leucoginase Vial, Leunase Vial, Oncoginase Vial, Onconase Vial. International- Elspar. Why it is prescribed (Indications) : This medication is an antineoplastic agent, prescribed for lymphocytic leukemia either alone or with other medications. It stops cancer cell growth. When it is not to be taken (Contraindications): Contraindicated in patients with inflammation of pancreas and bleeding due to prior therapy with this medication and hypersensitivity.
Dosage & When it is to be taken : The recommended dose of elspar is 6, 000 International Units/m² intramuscularly (IM) or intravenously (IV) three times a week. How it should be taken : It comes as a solution for injection to be administered by a healthcare provider into the vein or into the large muscle. Warnings and Precautions : * Caution should be exercised in patients with history of liver, kidney or pancreatic disease, any allergy, who are taking other medications, elderly, during pregnancy and breast-feeding. * It may cause dizziness or drowsiness, do not drive a car or operate machinery while taking this medication. * It may reduce platelet counts, avoid injury or bruising. * Avoid any vaccination during the treatment period. Side Effects : Nausea and vomiting, loss of appetite, depression, tiredness, confusion, restlessness or agitation and headache. * Monitor complete blood counts, uric acid level and blood glucose level regularly while taking this medication. * Avoid using contaminated solution of this medication. * Avoid excess dosage. Storage Conditions : Normally handled and stored by healthcare providers. |
 Comment & Contribute
| ||
Browse the Drugs alphabetically
Reference
- Food and Drug Administration (FDA)
- National Institutes of Health (NIH)
- PubMed
- CIMS
- Indian Pharma Reference Guide 2012
Drugs Index
Price List 
Pharma Links
Recently added Drugs
Quick Links
Ask an Expert
